LANIER BIOTHERAPEUTICS
DEAD

Serial Number

97059971

Owner

Lanier Biotherapeutics, Inc

Attorney

Susan Piascik Christoff

Filing Date

Oct 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LANIER BIOTHERAPEUTICS Trademark

Serial Number: 97059971

LANIER BIOTHERAPEUTICS is a trademark filed by Lanier Biotherapeutics, Inc on October 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Lanier Biotherapeutics, Inc

150 Ben Burton Road
Bogart, GA 30622

Entity Type: 03

Trademark Details

Filing Date

October 5, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Pharmaceuticals for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; therapeutic preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; biological preparations for the treatment or prevention of dermatological, oncological, autoimmune, respiratory, inflammatory and ocular diseases, disorders and conditions; ophthalmic preparations

Scientific, medical and pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; research and development of biologics; research and development services in the field of antibodies; medical and scientific research, namely, conducting clinical trials and testing services; information, advisory and consultancy services in relation to all of the foregoing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 22, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 16, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 16, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 16, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2022 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 20, 2022 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jul 20, 2022 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jul 20, 2022 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jul 20, 2022 CPEA
ASSIGNED TO EXAMINER
Jul 8, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 30, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 29, 2021 NWOS
NEW APPLICATION ENTERED
Oct 8, 2021 NWAP